Seeking sanity in microbiology diagnostics. Love running & swimming. Keen semi-amateur photographer! All my teams play in blue. Up the yeltz! tweets my own.
@conkers3@HTVIOLA Also interesting mention of Porvair. That was one of the first shares that a workplace investment club I was a member of purchased back in maybe mid/late 2000. We likely paid around a £1 a share at the time. I am tempted to look again at this one!
@conkers3 Great Pod - nice listen for my very warm run this AM. Was great follow up on Keller PLC - I heard podcast last year - Aug ? When @HTVIOLA mentioned Keller - I followed up and researched and bought in - have sold now at c120% uplift as wanted more Avingtrans!
🎟️ Win a pair of tickets to Investor Summit 2025! 🎟️
Discover key investment insights at the new Investor Summit in the City of London. Connect with top fund managers, industry experts, and peers through informative keynotes, interactive panels, and valuable networking opportunities.
To enter:
1️⃣ Like and retweet this post
2️⃣ Follow us @_investorsummit
Winner announced at the end of next week! Don't miss out.
#investing #finance
@conkers3@HTVIOLA My Five for 2025
WG. Wood Group Plc
ITV ITV Plc
IES Invinity Energy Systems Plc
ONT Oxford Nanopore Plc
ITM ITM Power Plc
Undervalued UK technology/industrial and potential for takeovers in 2025 if valuation gaps continue vs US businesses.
Irish Researchers, Serosep Partner to Develop Ulcerative Colitis Disease Progression Test. RCSI researchers have found a set of genes that are highly expressed in ulcerative colitis patients that progress to further stages of the disease that they... https://t.co/MqPMsfOkfh
@conkers3#TwinPetesInvesting
My five stocks for 2024 competition
BOOM audioboom plc
SEE Seeingmachines plc
STX Shield Therapeutics plc
POLB Poolbeg Pharma PLC
DEST Destiny Pharma PLC
#SWACM2023 attendees, join us for a complimentary breakfast this Friday and learn more about our mission to provide targeted antimicrobial treatment through advanced single-cell microbiology.
Just a few days away! Join us in Anaheim next week for #2023AACC, where we will be showcasing our single-cell microbiology technology in the Disruptive Technologies area, space #2703.
@conkers3 MASIMO is a med tech in non invasive monitoring, oxygen satn and alike. revenue and margins decent, sold off after aquisition in consumer audio which looks overdone IMHO. Mentioned on investing matters by Todd Wenning from ensemble capital. Recovery play /future growth etc
Off-label novel application of diagnostic multiplex molecular platforms for environmental detection of Carbapenemase-producing Enterobacterales:
https://t.co/aTmQasLzYP
The next six weeks are the biggest shop window that non-league has ever had.
Football at this level is about as far removed from Qatar as you can imagine. It’s the beautiful game as it used to be. 💙
So why not take this opportunity to go and watch your local side?
@fennel_h@robshorten Not saying I am diagnostics assay need but would likely be early 80s. Have been in lab since 90 and don't remember seeing that ad. Api been about since late 70s specially the E/NE was Analytab before biomerieux bought. Nearly 50 Yr old tech but still works well if done properly.
Been curious to learn more about our developing technology? Check out this @CARB_X profile to see how we intend to address a critical need with our rapid phenotypic diagnostics. #TBT
https://t.co/RHYIEwluog